| Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) (NCT05461430) | Travera Inc | 2022-07-15 |
| The Combination Chemotherapy of SIRIOX as First- or Second-Line Chemotherapy for Pancreatic Cancer (NCT03403101) | Fudan University | 2020-07-01 |
| Ultrasound-enhanced Uptake of Chemotherapy in Patients With Inoperable Pancreatic Ductal Adenocarcinoma (NCT04146441) | St. Olavs Hospital | 2020-02-10 |
| Impact of Nationwide Enhanced Implementation of Best Practices in Pancreatic Cancer Care (PACAP-1) (NCT03513705) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2018-05-22 |
| Detection of MicroRNA-25 in the Diagnosis of Pancreatic Cancer (NCT03432624) | Fudan University | 2018-03-01 |
| Establishing Organoids From Metastatic Pancreatic Cancer Patients, the OPT-I Study. (NCT03500068) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2017-09-04 |
| A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma (NCT02993731) | Sumitomo Pharma America, Inc. | 2016-12-01 |
| Correlation of Serum CA19-9 Levels With Levels in Saliva and Urine of Patients With Ductal Adenocarcinoma of the Pancreas (NCT02817308) | Rambam Health Care Campus | 2016-07-01 |
| Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors (NCT02658214) | AstraZeneca | 2016-04-28 |
| Standard Versus Extended Lymphadenectomy in Pancreatoduodenectomy for Patients With Pancreatic Head Adenocarcinoma (NCT02928081) | West China Hospital | 2016-01-01 |
| Study of Changes and Characteristics of Genes in Patients With Pancreatic Cancer for Better Treatment Selection (NCT02750657) | University Health Network, Toronto | 2015-12-01 |
| Parvovirus H-1 (ParvOryx) in Patients With Metastatic Inoperable Pancreatic Cancer (NCT02653313) | Oryx GmbH & Co. KG | 2015-12-01 |
| According CTC to Compare the Influences of Different Methods to Remove the PDAC (NCT02451384) | Shanghai Zhongshan Hospital | 2015-06-01 |
| Safety and Efficacy Evaluation of iAPA-DC/CTL Combined Gemcitabine Therapy on Advanced Pancreatic Cancer (NCT02529579) | Changhai Hospital | 2015-06-01 |
| Continuous Monitoring on the General Ward (NCT02933307) | Radboud University Medical Center | 2015-04-01 |
| Pancreatic Cancer Can be Detected by Adrenomedullin in New Onset Diabetes Patients (NCT02456051) | University of Roma La Sapienza | 2015-04-01 |
| Circulating Tumor Cells in Operative Blood (NCT02150746) | University of Florida | 2015-02-01 |
| An Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI Endoscopy (NCT02310230) | Donald Mathews | 2014-09-22 |
| A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002 (NCT01608711) | Agensys, Inc. | 2012-08-07 |
| A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors (NCT01478685) | Celgene | 2011-11-29 |
| Chemotherapy Selection Based on Therapeutic Targets for Advanced Pancreatic Cancer (NCT01394120) | Sofia Perea, Director Clinical Trials Unit. | 2011-08-01 |
| Amatuximab for High Mesothelin Cancers (NCT01413451) | National Cancer Institute (NCI) | 2011-07-12 |
| Selective Extended Dissection in Different Types of Pancreatic Head Cancer: A Retrospective Cohort Study. (NCT05723978) | Tianjin Medical University Cancer Institute and Hospital | 2011-01-01 |
| A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer (NCT00902291) | Astellas Pharma Inc | 2009-04-01 |
| Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer. (NCT00471146) | Pfizer | 2007-07-01 |
| Efficacy Study of Gemcitabine, Paclitaxel, and Irradiation in the Treatment of Pancreatic Cancer (NCT00226746) | New York Presbyterian Brooklyn Methodist Hospital | 2003-03-01 |